Michael Garcia

1.7k total citations
21 papers, 933 citations indexed

About

Michael Garcia is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Michael Garcia has authored 21 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Surgery. Recurrent topics in Michael Garcia's work include Ovarian cancer diagnosis and treatment (4 papers), Pluripotent Stem Cells Research (3 papers) and Circadian rhythm and melatonin (3 papers). Michael Garcia is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Pluripotent Stem Cells Research (3 papers) and Circadian rhythm and melatonin (3 papers). Michael Garcia collaborates with scholars based in United States and Germany. Michael Garcia's co-authors include Peter G. Schultz, Charles Y. Cho, Steve A. Kay, Tsuyoshi Hirota, Achim Brinker, Jae Wook Lee, Eric C. Peters, Ralph S. Freedman, Costas A. Lyssiotis and Rudolf Jaenisch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Michael Garcia

20 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Garcia United States 13 459 192 153 128 110 21 933
Zhixin Qiu China 14 838 1.8× 160 0.8× 328 2.1× 141 1.1× 30 0.3× 22 1.4k
Leo J.Y. Kim United States 13 801 1.7× 157 0.8× 292 1.9× 254 2.0× 35 0.3× 18 1.3k
Ryan C. Gimple United States 21 1.6k 3.5× 162 0.8× 510 3.3× 293 2.3× 64 0.6× 32 2.4k
Kevin C. Flanagan United States 10 331 0.7× 113 0.6× 181 1.2× 259 2.0× 48 0.4× 21 825
Nariman Ansari Germany 13 216 0.5× 162 0.8× 174 1.1× 70 0.5× 85 0.8× 14 750
Hye Jin Nam South Korea 16 707 1.5× 43 0.2× 160 1.0× 77 0.6× 57 0.5× 28 953
Frederike Dijk Netherlands 20 488 1.1× 86 0.4× 319 2.1× 141 1.1× 203 1.8× 48 1.1k
Cyril Esnault France 11 658 1.4× 113 0.6× 90 0.6× 54 0.4× 40 0.4× 16 910
Xiaochao Tan United States 17 636 1.4× 81 0.4× 156 1.0× 80 0.6× 25 0.2× 31 955

Countries citing papers authored by Michael Garcia

Since Specialization
Citations

This map shows the geographic impact of Michael Garcia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Garcia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Garcia more than expected).

Fields of papers citing papers by Michael Garcia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Garcia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Garcia. The network helps show where Michael Garcia may publish in the future.

Co-authorship network of co-authors of Michael Garcia

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Garcia. A scholar is included among the top collaborators of Michael Garcia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Garcia. Michael Garcia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gray, Stacy W., Ilana Solomon, Heather Hampel, et al.. (2024). Universal germline testing for cancer susceptibility and actionable noncancer disorders among 19,842 patients: Initial findings from the City of Hope INSPIRE study.. Journal of Clinical Oncology. 42(16_suppl). 10594–10594.
2.
Coleman, Robert L., Wei Hu, Pamela T. Soliman, et al.. (2021). Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study. Gynecologic Oncology. 161(1). 104–112. 7 indexed citations
3.
Grassi, Paul A., Michael Garcia, & J. Fenton. (2017). Digital Identity Guidelines (Revised Draft). 1 indexed citations
4.
Garcia, Michael, et al.. (2015). Privacy Risk Management for Federal Information Systems. 12 indexed citations
5.
Jhingran, Anuja, Lois M. Ramondetta, Diane C. Bodurka, et al.. (2013). A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I–IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecologic Oncology. 129(2). 304–309. 20 indexed citations
6.
Staerk, Judith, Costas A. Lyssiotis, Michael J. Bollong, et al.. (2011). Pan‐Src Family Kinase Inhibitors Replace Sox2 during the Direct Reprogramming of Somatic Cells. Angewandte Chemie International Edition. 50(25). 5734–5736. 44 indexed citations
7.
Lee, Jae Wook, Tsuyoshi Hirota, Eric C. Peters, et al.. (2011). A Small Molecule Modulates Circadian Rhythms through Phosphorylation of the Period Protein. Angewandte Chemie International Edition. 50(45). 10608–10611. 50 indexed citations
8.
Coleman, Robert L., Linda Duska, Pedro T. Ramírez, et al.. (2011). Phase 1–2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. The Lancet Oncology. 12(12). 1109–1117. 66 indexed citations
9.
Staerk, Judith, Costas A. Lyssiotis, Michael J. Bollong, et al.. (2011). Pan‐Src Family Kinase Inhibitors Replace Sox2 during the Direct Reprogramming of Somatic Cells. Angewandte Chemie. 123(25). 5852–5854. 3 indexed citations
10.
Lee, Jae Wook, Tsuyoshi Hirota, Eric C. Peters, et al.. (2011). A Small Molecule Modulates Circadian Rhythms through Phosphorylation of the Period Protein. Angewandte Chemie. 123(45). 10796–10799. 1 indexed citations
11.
Vargas, Leonardo, Michael Garcia, Yury J. Sigal, et al.. (2010). HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1. PubMed. 4. 9–18. 16 indexed citations
12.
Hirota, Tsuyoshi, Jae Wook Lee, Warren G. Lewis, et al.. (2010). High-Throughput Chemical Screen Identifies a Novel Potent Modulator of Cellular Circadian Rhythms and Reveals CKIα as a Clock Regulatory Kinase. PLoS Biology. 8(12). e1000559–e1000559. 197 indexed citations
13.
Garcia, Michael, Yirong Lin, & Henry A. Sodano. (2010). Autonomous materials with controlled toughening and healing. Journal of Applied Physics. 108(9). 16 indexed citations
14.
Lyssiotis, Costas A., Ruth K. Foreman, Judith Staerk, et al.. (2009). Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proceedings of the National Academy of Sciences. 106(22). 8912–8917. 282 indexed citations
15.
Adams, Deanna G., Yu Wang, Puiying A. Mak, et al.. (2008). Cellular Ser/Thr-Kinase Assays Using Generic Peptide Substrates. PubMed. 1. 54–64. 4 indexed citations
16.
Lenzi, Renato, Robert P. Edwards, Carl H. June, et al.. (2007). Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma. Journal of Translational Medicine. 5(1). 66–66. 62 indexed citations
17.
Apte, Sachin M., Saroj Vadhan‐Raj, Lorenzo Cohen, et al.. (2006). Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin. Journal of Translational Medicine. 4(1). 16–16. 11 indexed citations
18.
Melichar, Bohuslav, Renato Lenzi, Michael Rosenblum, et al.. (2003). Intraperitoneal Fluid Neopterin, Nitrate, and Tryptophan After Regional Administration of Interleukin-12. Journal of Immunotherapy. 26(3). 270–276. 12 indexed citations
19.
Freedman, Ralph S., Saroj Vadhan‐Raj, Cherié Butts, et al.. (2003). Pilot study of Flt3 ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas.. PubMed. 9(14). 5228–37. 55 indexed citations
20.
Meier, Donald A., et al.. (1997). Graves' disease triggered by autoinfarction of an autonomously functioning thyroid adenoma.. PubMed. 38(2). 260–2. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026